Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BASF Plant Science GmbH holds a company patent portfolio centered on the Biotechnology & Pharmaceuticals technology area. At present, the portfolio contains 1 pending office action. This activity is being reviewed by 1 distinct examiner. This focus is further evidenced by the involvement of 1 distinct art unit. Such a concentrated prosecution profile suggests that the intellectual property is focused on a specific area within the broader biotechnology field.
The busiest examiner for this portfolio is KOVALENKO, MYKOLA V, who is assigned the 1 pending office action. Since the total count of pending office actions is 1, this examiner manages the active portion of the portfolio. This creates an environment where the success of the current prosecution efforts rests with 1 individual. Practitioners should focus on the specific examination history and tendencies of KOVALENKO, MYKOLA V, as there are no other examiners or art units currently influencing the portfolio trajectory.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOVALENKO, MYKOLA V | 1 | 69.5% | +25.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 14790279 | AHAS MUTANTS | KOVALENKO, MYKOLA V | 53d |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 14790279 | AHAS MUTANTS | KOVALENKO, MYKOLA V | 1662 | §103 | Final Rejection | 53d | Pending | Jul 02, 2015 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial